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Abstract
Many studies have demonstrated that prompt appropriate treat-
ment for the critically ill patient improves outcome. Moving patients
to the best place for instituting care, however, is not always
associated with improved outcome. Recent studies on delivering
patients to the best place for treatment as well as further work on
the effects of volume are discussed. Finally, a large retrospective
cohort study comparing outcomes of patients treated with continu-
ous venovenous haemofiltration or intermittent haemodialysis is
outlined.
“Nothing is permanent but change”
Heraclitus, circa 500 BC
For those of us practicing in the United Kingdom, the National
Health Service is approaching its 60th birthday and, far from
being pensioned off, there is much political will to change the
way healthcare is being delivered in a radical fashion. This
reinvention of the National Health Service is being applied
across the board, including the critical care arena, and an
often-used phrase is that of ‘reconfiguration’ of services. This
will probably lead, in time, to fewer critical care units in
England and to more patients being transferred between
hospitals.
Two papers published in Critical Care Medicine therefore
make interesting reading for those of us swept up in this
maelstrom. Golestanian and colleagues performed a cohort
observational study examining the effects of interhospital
transfers on resource utilisation and outcomes at a tertiary
care referral centre in the USA [1]. They compared patients
transferred from other hospitals with those admitted ‘in-
house’ from the A&E department or the wards. The patients
transferred had higher Acute Physiology and Chronic Health
Evaluation III scores (60.5 versus 49.7), higher intensive care
unit (ICU) mortality (14% versus 8%) and higher hospital
mortality (22% versus 14%). The length of stay was also
longer in terms of both ICU bed days and hospital bed days.
These results are in keeping with several other studies [2,3].
When stratified by disease severity using the Acute
Physiology and Chronic Health Evaluation III model, however,
the crude mortality differences were less striking, with no
statistical differences observed. What did remain significantly
different was the cost of treatment. On average, a patient
transferred to the ICU from outside the institution cost about
$10,000 more per admission. Somewhat surprisingly, this
difference was principally confined to the group with the
lowest predicted mortality – the reasons for which remain
unclear. Does this mean that transferring patients has no
impact other than financial? Probably not, as case mix also
plays a significant role – an earlier study on medical ICU
patients demonstrated that, even after accounting for disease
severity, transferred patients had a significantly higher
mortality rate [4]. This has also been backed up by findings in
Europe [5].
Following on from this study is a paper from Chalfin and
colleagues, who examined the impact of a delay in transfer of
critically ill patients from the A&E department (or the
emergency department, if you prefer) to the ICU using cross-
sectional analysis of the multicentre US Project Impact
Database of ICU patients [6]. Patients were divided into two
groups: those remaining in the A&E department for longer
than 6 hours (referred to as ‘boarding’ patients), and those
patients transferred in under 6 hours. The 6-hour value was
selected as it correlates with the 5.8-hour period reported as
the mean time to transfer from the A&E department to an ICU
bed in American hospitals that report overcrowding in the
A&E department. The data from over 50,000 patients were
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examined, of which just over 1,000 were classed as ‘boarders’,
and there was no significant difference in baseline
characteristics between the two groups. Unsurprisingly, the
boarders faired less well – their ICU mortality was higher
(10.7% versus 8.4%), the inhospital mortality was higher
(17.4% versus 12.9%) and the median stay of survivors was
1 day longer. The boarding patients also required more
frequent ventilation and more invasive haemodynamic
monitoring than transferred patients.
So what do these studies tell us? Certainly they highlight
some of the similarities between the United States and the
United Kingdom with respect to overburdened emergency
services. The United States is seeing consistent increases in
the volume of and illness severity of patients presenting to the
A&E department, just as we are observing in the United
Kingdom. The studies also confirm what many of us believe
and what may be viewed as ‘critical care arrogance’: that is,
the critically ill are best looked after in the ICU environment
with the skills, time and staff to recognise, and react to,
physiological deterioration. The latter study does have several
weaknesses, which the authors themselves point out. The
study is retrospective and there is no ability within the data
trawling to identify causes of delay. There is a lack of
institutional data and, as such, a few underperforming centres
may therefore have contributed to the majority of delayed
transfers, which may be explained by other factors
independent of ‘boarding’. The Acute Physiology and Chronic
Health Evaluation II data were limited to about 60% of
patients and also the ‘boarders’ only contributed just over 2%
of the sample. As the accompanying editorial points out,
however, hopefully this will lead to seeking innovative ways to
avoid delays in transferring to ICU care – and to avoid doing
so is ‘inefficient, expensive and deadly’ [7].
For those involved in redesigning services in the United
Kingdom, one hopes that these studies will be borne in mind,
although advocates of specialist centralisation will point to
the evidence supporting this approach. This leads on to a
study by Peelen and colleagues published in this journal
examining the influence of volume and ICU organisation on
hospital mortality in patients admitted with severe sepsis [8].
This was a retrospective cohort study using the Dutch
national intensive care database that employed question-
naires sent to the participating units. An impressive response
rate of over 90% was achieved. More than 4,500 patients
were analysed, and the risk-adjusted mortality rates demon-
strated that there was lower inhospital mortality in units that
treated a higher volume of sepsis. Unexpectedly, several
other factors were also associated with a higher mortality.
Those hospitals with a ‘step-down’ facility were associated
with a higher probability of inhospital death, as was the
number of intensivists per bed, although no association
between the availability of an intensivist outside working
hours and mortality was observed. This may in part be
explained by the excellent provision of ICU-trained doctors in
The Netherlands. The authors do call for further studies on
the volume:outcome relationship in the intensive care arena,
but also state that ‘the findings of the present study are not
sufficient to support regionalization of ICU care for severe
sepsis patients’ [8]. They also point out that ‘transportation to
a high-volume, regionalized severe sepsis centre might do
more harm than immediate treatment in an ICU with a low
sepsis volume’, which brings us back to the work by
Golestanian and colleagues.
What is clear is that there is a growing body of evidence
demonstrating that improved intensive care outcomes are
associated with increased volume of the ICU [9-11]. But
where do policy-makers go from here? Clearly there is a need
for further prospective studies, and if these help elucidate
some of the critical factors then these factors may be
addressed. The problem may lie in what strategies will be
employed to address the inequalities in outcome. Some may
advocate a centralised system with the incumbent dangers in
transfer, although the knock-on effects may also be felt in an
erosion of local expertise and the range of services offered.
Others may suggest exportation of training, enforced
protocols and ‘care bundles’. At present there is no easy
answer but change will almost certainly ensue, hopefully to
the benefit of our patients.
There are many contentious issues in the treatment of the
critically ill patient regarding what is best practice. One of the
arguments that continue to rage is that of the delivery of renal
support, with advocates of all modalities continuing to
promote their favoured technique. However, there is not a
great deal of information with regard to long-term follow up.
The paper by Bell and colleagues examines data from 32
Swedish ICUs (the SWING group) as a retrospective cohort
study between 1995 and 2004 [12]. The quality of data
collection is impressive and over 2,000 patients were studied
with no discernable differences in baseline characteristics,
although patients with sepsis were more likely to receive
continuous renal replacement therapy (CRRT). Approximately
50% of the patients died within 90 days, with no differences
noted between those treated with CRRT or intermittent
haemodialysis (IHD). Of the cohort surviving longer than
90 days the patients treated with CRRT had a better recovery
of renal function than those treated with IHD, as judged by
the need for chronic renal replacement therapy. The study
does have limitations – no data regarding severity of illness
are available (although it is implied that those treated with
CRRT were sicker) and there is a lack of information
regarding the dose and the length of dialysis. Interestingly the
study does demonstrate a marked change in practice – the
use of continuous techniques increases with time, with 76%
of the IHD-treated cohort being treated before 2000, which
may also affect the observed results. How does this affect the
choice of renal replacement therapy? Bell and colleagues’
study cannot answer this question, but one criticism of CRRT
is the expense; however, if IHD is associated with a greaterPage 3 of 3
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need for chronic dialysis, then this also has significant
financial implications as well as the burden of comorbidity
associated with chronic renal disease.
Competing interests
LF works in the NHS and wishes to preserve its integrity.
References
1. Golestanian E, Scrugs JE, Gangon RE, Mak RP, Wood KE: Effect
of interhospital transfer on resource utilization and outcomes
at a tertiary referral center. Crit Care Med 2007,  35:1470-
1476.
2. Borlase BC, Baxter JK, Kenney PR, Forse RA, Benotti PN, Black-
burn GL: Elective intrahospital admissions versus acute inter-
hospital transfers to a surgical intensive care unit: cost and
outcome prediction. J Trauma 1991, 31:915-918.
3. Escarce JJ, Kelley MA: Admission source to the medical inten-
sive care unit predicts hospital death independent of APACHE
II score. JAMA 1990, 264:2389-2394.
4. Rosenberg AL, Hofer TP, Strachan C, Watts CM, Hayward RA:
Accepting critically ill transfer patients: adverse effect on a
referral center’s outcome and benchmark measures. Ann
Intern Med 2003, 138:882-890.
5. Combes A, Luyt CE, Trouillet JL, Chastre J, Gibert C: Adverse
effect on a referral intensive care unit’s performance of
accepting patients transferred from another intensive care
unit. Crit Care Med 2005, 33:705-710.
6. Chalfin DB, Trzeciak S, Likourezos A, Baumann BM, Dellinger RP:
Impact of delayed transfer of critically ill patients from the
emergency department to the intensive care unit. Crit Care
Med 2007, 35:1477-1483.
7. Gregory CJ, Marcin JP: Golden hours wasted: the human cost
of intensive care unit and emergency department inefficiency.
Crit Care Med 2007, 35:1614-1615.
8. Peelen L, de Keizer NF, Peek N, Scheffer GJ, van der Voort PHJ,
de Jonge E: The influence of volume and intensive care unit
organization on hospital mortality in patients admitted with
severe sepsis: a retrospective multicentre cohort study. Crit
Care 2007, 11:R40.
9. Durairaj L, Torner JC, Chrischilles EA, Vaughan Sarrazin MS,
Yankey J, Rosenthal GE: Hospital volume–outcome relation-
ships among medical admissions to ICUs. Chest 2005, 128:
1682-1689.
10. Glance LG, Li Y, Osler TM, Dick A, Mukamel DB: Impact of
patient volume on the mortality rate of adult intensive care
unit patients. Crit Care Med 2006, 34:1925-1934.
11. Kahn JM, Goss CH, Heagerty PJ, Kramer AA, O’Brien CR, Ruben-
feld GD: Hospital volume and the outcomes of mechanical
ventilation. N Engl J Med 2006, 355:41-50.
12. Bell M, Granath F, Schön S, Ekbom A, Martling R-L: Continuous
renal replacement therapy is associated with less chronic
renal failure than intermittent haemodialysis after acute renal
failure. Intensive Care Med 2007, 33:773-780.
Available online http://ccforum.com/content/11/4/155